Want to join the conversation?
$ESRX's home delivery and specialty revenues for 2015 increased by 5.7% from last year. This rise relates primarily to inflation on branded drugs, partially offset by lower claims volume and rise in home delivery generic fill rate. Home delivery generic fill rate rose to 79.5% of home delivery claims in 2015 from 77.2% in 2014.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th